Trial Profile
Response rates in liver transplant patients treated with Simeprevir + Sofosbuvir for patients with recurrent Hepatitis C and taking concurrent standard immunosupression therapy.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ciclosporin; Tacrolimus
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2015 New trial record